Animal Health Active Pharmaceutical Ingredients
SKU
MRR-430D3EB72270
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 17.41 billion
2030
USD 30.28 billion
2024
USD 18.82 billion
CAGR
8.23%
Animal Health Active Pharmaceutical Ingredients Market by Business (Captive Active Pharmaceutical Ingredient, Merchant Active Pharmaceutical Ingredient), Indication (Anti-Infectives, Antiparasitics, Non-Steroidal Anti-Inflammatory Drugs & Anesthetics), Synthesis, Type, End User - Global Forecast 2024-2030

[189 Pages Report] The Animal Health Active Pharmaceutical Ingredients Market size was estimated at USD 17.41 billion in 2023 and expected to reach USD 18.82 billion in 2024, at a CAGR 8.23% to reach USD 30.28 billion by 2030.

Animal Health Active Pharmaceutical Ingredients Market
To learn more about this report, request a free sample copy
Animal Health Active Pharmaceutical Ingredients Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Health Active Pharmaceutical Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Health Active Pharmaceutical Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Health Active Pharmaceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Limited, Glenmark Pharmaceutical Ltd., Heska Corporation, HIKAL Ltd., Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ofichem BV, Orion Corporation, Sequent Scientific Ltd., Suanfarma, SA, Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Health Active Pharmaceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Business
    • Captive Active Pharmaceutical Ingredient
    • Merchant Active Pharmaceutical Ingredient
  • Indication
    • Anti-Infectives
    • Antiparasitics
    • Non-Steroidal Anti-Inflammatory Drugs & Anesthetics
  • Synthesis
    • Biotech
    • Synthetic
  • Type
    • Branded
    • Generic
  • End User
    • Pet Care Hospitals
    • Retail & Specialty Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Animal Health Active Pharmaceutical Ingredients Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Health Active Pharmaceutical Ingredients Market?
  3. What are the technology trends and regulatory frameworks in the Animal Health Active Pharmaceutical Ingredients Market?
  4. What is the market share of the leading vendors in the Animal Health Active Pharmaceutical Ingredients Market?
  5. Which modes and strategic moves are suitable for entering the Animal Health Active Pharmaceutical Ingredients Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Animal Health Active Pharmaceutical Ingredients Market, by Business
  7. Animal Health Active Pharmaceutical Ingredients Market, by Indication
  8. Animal Health Active Pharmaceutical Ingredients Market, by Synthesis
  9. Animal Health Active Pharmaceutical Ingredients Market, by Type
  10. Animal Health Active Pharmaceutical Ingredients Market, by End User
  11. Americas Animal Health Active Pharmaceutical Ingredients Market
  12. Asia-Pacific Animal Health Active Pharmaceutical Ingredients Market
  13. Europe, Middle East & Africa Animal Health Active Pharmaceutical Ingredients Market
  14. Competitive Landscape
  15. Competitive Portfolio
Companies Mentioned
  • Changzhou Yabang-Qh Pharmachem Co., Ltd.
  • Eli Lilly & Co.
  • Excel Industries Limited
  • Glenmark Pharmaceutical Ltd.
  • Heska Corporation
  • HIKAL Ltd.
  • Indukern, S.A.
  • Lonza Group AG
  • NGL Fine Chem Ltd.
  • Ofichem BV
  • Orion Corporation
  • Sequent Scientific Ltd.
  • Suanfarma, SA
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Zoetis Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Animal Health Active Pharmaceutical Ingredients Market
The Global Animal Health Active Pharmaceutical Ingredients Market size was estimated at USD 17.41 billion in 2023 and expected to reach USD 18.82 billion in 2024.
The Global Animal Health Active Pharmaceutical Ingredients Market to grow USD 30.28 billion by 2030, at a CAGR of 8.23%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.